Zoetis Welcomes Officials to Celebrate New R&D Building in Durham, N.C.
24 Août 2023 - 8:32PM
Business Wire
Zoetis:
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230824033227/en/
Zoetis executives, along with North
Carolina Representative Zack Hawkins, marked the official opening
of the company's new building in Durham, N.C. The site is dedicated
to diagnostics and biodevices research and development. Source:
Zoetis
NEWS FACTS
- Today, Zoetis, the world leader in Animal Health, marked the
official opening of its new building dedicated to diagnostics and
biodevices research and development with a ribbon cutting ceremony
at its site in Durham, N.C.
- The ceremony was attended by local officials, including North
Carolina Secretary of Commerce Machelle Baker Sanders, North
Carolina Representative Zack Hawkins and key company leaders
including Zoetis CEO Kristin Peck, and President of Research and
Development Rob Polzer.
- The expanded site serves as the hub for Zoetis’ engineering and
diagnostics work including device reliability testing. The new
building features more than 78,000 square feet including 23,000
square feet of total lab space allotted for a biodevice engineering
lab, biodevice science lab, diagnostics engineering lab and
diagnostics engineering lab space.
- Zoetis has added 54 jobs to its diagnostics and biodevices
research and development team in Durham in the last three
years.
ZOETIS IN DURHAM
- Zoetis’ site in Durham, N.C., is a crucial part of the
company’s global research and development locations around the
world. It serves as the company’s R&D hub for diagnostics and
engineering capabilities.
- Zoetis employs approximately 200 people at its site in Durham,
more than half of whom are dedicated to the company’s R&D work.
Other colleagues on site are dedicated to U.S. Poultry, Global
BioDevices commercial operations, as well as related manufacturing
and enabling functions.
- Zoetis, and before that Embrex, has had a presence in Durham,
N.C., for more than 30 years.
QUOTES
“We are thrilled to celebrate our new building in Durham, where
our research and development team dedicated to diagnostics and
engineering is based. As the innovation leader in animal health,
it’s important to us to be part of the dynamic technology community
here in Durham,” said Rob Polzer, Executive Vice President and
President of Research and Development at Zoetis. “I am optimistic
about our ability to continue to innovate in diagnostics and
biodevices to meet the needs of our customers and the pets and
livestock they care for.”
“Our colleagues in Durham have a long history of purpose-driven
innovation that transforms animals’ lives – from our Embrex
biodevice that’s helped automate and revolutionize poultry
hatcheries in the U.S. and markets around the world to our growing
focus on diagnostics to help veterinarians deliver accurate results
more quickly to pet owners,” said Kristin Peck, CEO Zoetis. “Our
continued investment in innovation, research and development, and
manufacturing helps distinguish us as the global leader in animal
health.”
ABOUT ZOETIS
As the world’s leading animal health company, Zoetis is driven
by a singular purpose: to nurture our world and humankind by
advancing care for animals. After innovating ways to predict,
prevent, detect, and treat animal illness for more than 70 years,
Zoetis continues to stand by those raising and caring for animals
worldwide -- from veterinarians and pet owners to livestock farmers
and ranchers. The company’s leading portfolio and pipeline of
medicines, vaccines, diagnostics and technologies make a difference
in over 100 countries. A Fortune 500 company, Zoetis generated
revenue of $8.1 billion in 2022 with approximately 13,800
employees. For more information, visit www.zoetis.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230824033227/en/
Media:
Christina Lood Mobile: 646-853-0342
christina.lood@zoetis.com
Bill Price Mobile: 908-251-1972 william.price@zoetis.com
Zoetis (NYSE:ZTS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Zoetis (NYSE:ZTS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024